ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag monoclonal antibodies disease medicine culture

Monoclonal Antibodies Find Utility In Cell Biology
Ricki Lewis | Dec 11, 1994 | 10+ min read
But, just as antibodies are finding increasing utility in cell biology, a new Food and Drug Administration classification for those products with clinical utility may affect researchers' access to the important technology (see accompanying story). Monoclonal History MAbs were born in 1975, when Georges Kohler and Cesar Milstein at the Medical Research Council Laboratories in Cambridge, England, fused two types of cells to form a hy
Monoclonal Antibodies Find Utility In Cell Biology
Ricki Lewis | Dec 11, 1994 | 10+ min read
But, just as antibodies are finding increasing utility in cell biology, a new Food and Drug Administration classification for those products with clinical utility may affect researchers' access to the important technology (see accompanying story). Monoclonal History MAbs were born in 1975, when Georges Kohler and Cesar Milstein at the Medical Research Council Laboratories in Cambridge, England, fused two types of cells to form a hy
regeneron monoclonal antibody sars-cov-2 covid-19 pandemic coronavirus neutralization b.1.351 variant south africa REGN10987 casirivimab and REGN10933 imdevimab
Regeneron Cocktail Stumbles Against SARS-CoV-2 Variant in Vitro
Marcus A. Banks | Mar 1, 2021 | 3 min read
A treatment of two monoclonal antibodies against SARS-CoV-2 is ninefold less effective in the lab against the B.1.351 variant than against the dominant version of the virus.
Antibody Alternatives
Paul Ko Ferrigno and Jane McLeod | Feb 1, 2016 | 10+ min read
Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.
The Man Who Made Millions by Marketing Monoclonal Antibodies
Ann Gibbons | Mar 5, 1989 | 7 min read
SAN DIEGO—When Ivor Royston founded his first biotech company in 1978, the 33-year-old assistant professor at the University of California, San Diego had no idea it would make him so rich and...infamous. Royston did know he was taking a risk. But his idea, to start the first company in the nation to sell monoclonal antibodies to other labs, was so compelling that he decided to gamble his career at UCSD. “I had only been there a year. I wasn’t even tenured,” recalls
Antibodies could combat prion-based diseases
Simon Frantz(simonfrantz@hotmail.com) | Aug 1, 2001 | 3 min read
The discovery that antibodies seem to be effective against prions could open the door to immunisation against spongiform encephalopathies.
Toward Stopping MERS Spread
Tracy Vence | Apr 30, 2014 | 2 min read
Independent teams culture the Middle East respiratory system coronavirus and identify human antibodies that could inform therapies.
Faulty Antibodies Undermine Widespread Research
Ruth Williams | Jan 30, 2020 | 4 min read
Two papers reveal that many commonly used research antibodies don’t bind as believed, highlighting the need to validate these reagents before use.
2020 in Scientists’ Own Words
Abby Olena, PhD | Dec 23, 2020 | 5 min read
The world was rocked by the COVID-19 pandemic this year, but researchers rose to all manner of challenges.
New Immunoassay Products Let Users Put New Twists On Old Themes
Lisa Seachrist | Sep 29, 1996 | 8 min read
Advanced Chemtech AFfinity Bioreagents Biodesign International Bio-Rad Laboratories BioSource International Boehringer Mannheim Biochemicals Cardinal Associates Inc. Immunochemistry Technologies Peninsula Laboratories Inc. Tropix Inc. Wako Chemicals USA Inc. Wallac Inc. A quick inventory of nearly any molecular biology laboratory these days will turn up a kudzu-like infestation of monoclonal antibodies, fluorescent-tagged secondary antibodies, and immunoassay kits. Immunoassays have become de

Run a Search

ADVERTISEMENT